AMD

Easing patient comfort, pain perception of intravitreal injections

September 24, 2020

Study points to the possible role of addressing preprocedural anxiety

Taking a deeper dive: Novel gene therapy approaches to treat ocular disease

September 23, 2020

Investigators find that nanoparticles deliver gene therapy successfully in mice, rats

Bausch Health to acquire option to purchase ophthalmology assets of Allegro

September 21, 2020

Agreement would include global rights for investigational treatment, risuteganib, expected to help reverse vision loss due to dry AMD

Targeting AMD patient treatment burden

September 15, 2020

Intravitreal gene therapy continues to be well tolerated; shows robust efficacy

OCTA: Why the jury may still be out

September 11, 2020

Though OCTA has become indispensable for managing macular degeneration and diabetic retinopathy, Robert L. Stamper, MD, explains why the technology must become more sophisticated and evolved before it reaches its full potential for glaucoma specialists.

Regenxbio: Dosing of first patient in Phase 2 AAVIATE trial for wet AMD

September 09, 2020

Interim data update from first cohort using suprachoroidal delivery of RGX-314 expected by end of 2020